As more and more patients add CBD to their cannabis regimen, we will for certain find serum levels of THC being relatively “elevated” but with decreased or virtually no psycho activity. Let’s imagine a test or two:

For example, in test 1 give a patient, George, 25 mg of oral THC. Check serum THC levels at 30, 60, 90, min etc.

You would find very elevated THC serum levels and a patient that is clearly intoxicated. We will give poor George some very simple cognitive memory tests, such as “Name and age”. If you repeat the same test and give George say 25 mg of oral THC at first and then add 25 mg of CBD, and probably a lot less, the serum or blood levels of the THC will not be changed by any significant amount but George now remembers his name, age and much more.

So, is this a possible defense? MAYBE
Should we all carry around little tiny CBD bottles if “suddenly at risk”?? ALWAYS
Should we abandon serum levels? YES

Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.